Livingston Securities LLC

LIVINGSTON HEALTHCARE AND LIFE SCIENCE STAKEHOLDERS SUMMIT
Capturing Trends and Global Outlook: Advanced and Emerging Technologies
September 24, 2009 - 12:00-5:00pm
New York, NY 10036

CONFERENCE CHAIR: Mostafa Analoui, PhD, Head of Healthcare and Life Sciences
EVENT DIRECTOR: Jonathan Mason, jonathan@livingstonsecurities.com, 212-520-8479

OVERVIEW AND OBJECTIVES
This is a unique and by invitation-only conference to bring together key stakeholders from pharmaceutical, capital investment, business strategy and federal science and regulatory segments. Conference will include three topics, which are among top global issues for investors currently. Attendance in the conference is intended to be limited to assure open and interactive dialogue among participants during the sessions and networking breaks. This is intended to collectively identify key trends, as well as mutual opportunities among participants for deal making.

PROGRAM OUTLINE
INTRODUCTION: Overview and key investment indicators
SESSION I: Drug Discovery and Development: Early to Mid- Stage Fund Raise and Alliance
· Major Pharma
· Small/Emerging company view
· VC/PE
SESSION II: Diagnostics: Valuation and Future Directions
· Current Landscape
· Business/technology and finance
· Key future directions
SESSION III: Global and Emerging Investment Opportunities
· Overview and key players
· SPAC and Healthcare
· Global VCs and PEs

NETWORKING RECEPTION
Invitees include CEOs, CFOs, COOs for a broad range of pharmaceutical, diagnostic, and platform technology companies, a select number of US and International VCs and PEs, along with key policy makers and federal science and regulatory agencies.